Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial

IntroductionIn the UK and Ireland, severe and complex obesity is managed in specialist weight management services (SWMS), which provide multicomponent lifestyle interventions to support weight loss, and use of medication if available. Liraglutide 3 mg (LIRA 3 mg) is an effective weight-loss medicati...

Full description

Bibliographic Details
Main Authors: David Webb, Mike Lean, Werd Al-Najim, Barbara McGowan, Dimitris Papamargaritis, Jonathan Lim, James Crane, Carel le Roux, Donal O'Shea, John Wilding
Format: Article
Language:English
Published: BMJ Publishing Group 2020-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/2/e034137.full

Internet

https://bmjopen.bmj.com/content/10/2/e034137.full

Similar Items